Real-Time Kinetics of Interleukin-6 (IL-6) Predict Cytokine Release Syndrome (CRS) in Patients Receiving Chimeric Antigen Receptor (CAR) T-cell Therapy for relapsed/refractory B-cell Malignancies.

Transplantation and Cellular Therapy 2026

View at publisher
Authors: Agrima Mian, Rafaella Ferreira De Araujo Litvin, Jessica M Colón-Franco, Sujata Patil, Megan Molnar, Allison Marie Winter, Sandra Ann Mazzoni, Deepa Jagadeesh, Robert M. Dean, Jack Khouri, Faiz Anwer, Shahzad Raza
+7 more Aaron Thomas Gerds, Louis S. Williams, Betty K. Hamilton, John C. Molina, Claudio G. Brunstein, Brian Thomas Hill, Paolo Caimi
DOI: 10.1016/j.jtct.2025.12.217
Cited by: 0

Fields of Study & Subjects

CAR-T cell therapy research Immunotherapy and Immune Responses Cancer Immunotherapy and Biomarkers

Publication details

Journal / source
Transplantation and Cellular Therapy
Volume
32
Issue
2
Pages
S159–S159
Publication date
1 February 2026
Language
EN